Hiva Kolodrubetz, NP, provides an engaging and detailed session on anti-diabetic medications, focusing on safe prescribing and effective management strategies. Highlighting pharmacological mechanisms, A1C goals, and patient-centered care,…
Associate Professor Mike Todorovic, AKA “Dr. Mike”, introduces the endocrine system, explaining how hormones act as chemical messengers released into the bloodstream by cells, tissues, and glands. He…
NEW YORK (Reuters Health) – The cholesterol-lowering drug pravastatin prevents coronary heart disease in blacks, according to trial results published in the December American Heart Journal. “It’s very…
NEW YORK (Reuters Health) – Many common medications – including some antidepressants and antihypertensives – can interfere with a test that distinguishes Cushing’s syndrome from pseudo-Cushing’s syndrome, investigators…
NEW YORK (Reuters Health) – Pregnant women with type 1 diabetes had fewer severe hypoglycemic episodes when they started a preprandial insulin analog regimen before conception rather than…
NEW YORK (Reuters Health) – Bloodstream infections are more common with the use of needle-free mechanical valve connectors in intravascular catheters, a new study shows. The needle-free mechanical…
NEW YORK (Reuters Health) – In elderly heart failure patients with ejection fractions of 35% or less, implantable cardioverter defibrillators (ICD) can significantly improve long-term survival, according to…
NEW YORK (Reuters Health) – In patients with asymptomatic carotid stenosis (ACS), microemboli and cardiovascular events can be markedly reduced by aggressive medical therapy, Canadian research shows. This…
NEW YORK (Reuters Health) – In diabetic patients, sirolimus-eluting stents reduce the risk for coronary artery restenosis compared with paclitaxel-eluting stents, a meta-analysis shows. Because the relative efficacy…
NEW YORK (Reuters Health) – Treatment of depression in low-income minorities with poorly controlled diabetes improved HbA1c and systolic blood pressure, investigators report in the December issue of…
NEW YORK (Reuters Health) – In type 2 diabetics with multiple comorbidities, tight glycemic control does not provide the same cardiovascular benefits that it does in diabetics with…
NEW YORK (Reuters Health) – New research shows that antidiabetes agents are not equal when it comes to cardiovascular risks and mortality. According to a report in the…
